ArticleScientific reports2022

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer.

Sushmita B Gordhandas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.